Viewing Study NCT01536067


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-02-21 @ 9:25 PM
Study NCT ID: NCT01536067
Status: TERMINATED
Last Update Posted: 2016-06-10
First Post: 2012-02-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Waldenström Macroglobulinemia View
Keywords: